SG Pharma Solutions
SG PHARMASOLUTIONS
SG Pharma Solutions
SG PHARMASOLUTIONS
← Back to All Industries

Medical Devices

Comprehensive biological safety strategy, ISO 10993-18 chemical characterization, simulated-use study coordination, and ISO 14971 risk management integration for medical device manufacturers.

Sector Demands

Typical Industry Requirements

•Chemical characterization aligned with ISO 10993-18 and FDA guidance
•Biological Evaluation Plan (BEP) and Biological Evaluation Report (BER)
•Toxicological assessment coordination per ISO 10993-17 (TI/TE, Margin of Safety)
•Simulated-use and exaggerated extraction study execution
•Integration of chemical characterization data into ISO 14971 risk management files
Our Technical Scope

Relevant SG Pharma Solutions Capabilities

✓Constituent material assessment for polymers, elastomers, metals, and adhesives
✓Analytical Evaluation Threshold (AET) calculation based on patient contact duration
✓Coordination of solvent extraction and LC-MS / GC-MS / ICP-MS profiling with partner labs
✓Definitive toxicological risk evaluations for detected leachables
✓Technical authoring support for 510(k), PMA, and EU MDR CE technical documentation
Structured Collaboration

Typical Engagement Pathway

1
Biological Evaluation Planning (BEP)
2
Chemical Characterization Strategy & Testing
3
Toxicological Threshold Evaluation (ISO 10993-17)
4
Risk Management File Integration (ISO 14971)
5
Biological Evaluation Report (BER) Authoring
Direct Enquiry

Ready to Discuss Your Project?

Submit your technical requirements or product sourcing needs. Our technical team will review your specifications promptly.

Request Consultation →